We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.4%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$537B
AUM Growth
-$38.8B
Cap. Flow
-$65.7B
Cap. Flow %
-12.23%
Top 10 Hldgs %
26.27%
Holding
13,638
New
1,591
Increased
4,593
Reduced
5,607
Closed
1,726

Sector Composition

Rank Sector Weight
1 Technology 2.38%
2 Consumer Discretionary 1.03%
3 Financials 0.75%
4 Healthcare 0.67%
5 Communication Services 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTOS icon
11376
PUT
Custom Truck One Source
CTOS
$2.18B
$47.4K ﹤0.01%
10,900
-4,000
-27% -$19.5K
AMRN
11377
PUT
Amarin Corp
AMRN
$304M
$47.3K ﹤0.01%
3,425
-6,020
-64% -$103K
DRRX
11378
PUT
DELISTED
DURECT Corp
DRRX
$47.2K ﹤0.01%
36,600
+2,800
+8% +$3.29K
PSTX
11379
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$46.7K ﹤0.01%
16,006
-17,837
-53% -$48.8K
CRVS icon
11380
Corvus Pharmaceuticals
CRVS
$1.24B
$46.7K ﹤0.01%
25,650
-79,376
-76% -$148K
FRGE
11381
CALL
DELISTED
Forge Global Holdings
FRGE
$46.6K ﹤0.01%
2,127
-46
-2% -$1.22K
RGLS
11382
PUT
DELISTED
Regulus Therapeutics
RGLS
$46.5K ﹤0.01%
+26,000
New +$60.3K
TRVI icon
11383
CALL
Trevi Therapeutics
TRVI
$2.55B
$46.5K ﹤0.01%
+15,600
New +$43.3K
ZDGE icon
11384
Zedge
ZDGE
$38.4M
$46.5K ﹤0.01%
15,239
-2,150
-12% -$5.8K
CKPT
11385
PUT
DELISTED
Checkpoint Therapeutics
CKPT
$46.4K ﹤0.01%
21,600
-71,600
-77% -$127K
OMGA
11386
PUT
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$46.4K ﹤0.01%
22,400
-33,100
-60% -$78K
PXLW icon
11387
PUT
Pixelworks
PXLW
$41.2M
$46.4K ﹤0.01%
3,942
-8,733
-69% -$155K
VFF icon
11388
CALL
Village Farms International
VFF
$350M
$46.2K ﹤0.01%
45,300
-87,200
-66% -$106K
ALEC icon
11389
PUT
Alector
ALEC
$275M
$45.9K ﹤0.01%
+10,100
New +$52K
NKTR icon
11390
PUT
Nektar Therapeutics
NKTR
$2.52B
$45.8K ﹤0.01%
+2,460
New +$51.8K
LFWD icon
11391
CALL
ReWalk Robotics
LFWD
$21.2M
$45.7K ﹤0.01%
950
-200
-17% -$11.5K
DRIO icon
11392
DarioHealth
DRIO
$68.9M
$45.7K ﹤0.01%
+1,920
New +$54.4K
KOPN icon
11393
PUT
Kopin
KOPN
$879M
$45.6K ﹤0.01%
54,300
-32,700
-38% -$31.8K
RVPH
11394
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$45.6K ﹤0.01%
1,780
-935
-34% -$42.5K
LILM
11395
CALL
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$45.5K ﹤0.01%
57,600
+29,500
+105% +$27.7K
BETR icon
11396
Better Home & Finance Holding
BETR
$255M
$45.4K ﹤0.01%
1,979
+380
+24% +$7.64K
LVO icon
11397
PUT
LiveOne
LVO
$52.1M
$45.4K ﹤0.01%
2,890
+960
+50% +$17K
GLUE icon
11398
PUT
Monte Rosa Therapeutics
GLUE
$1.23B
$45.3K ﹤0.01%
12,100
+700
+6% +$3.57K
BRLT icon
11399
Brilliant Earth
BRLT
$21.6M
$45.2K ﹤0.01%
20,353
-13,692
-40% -$34.5K
RMCF icon
11400
Rocky Mountain Chocolate Factory
RMCF
$10.4M
$45K ﹤0.01%
+20,474
New +$64.6K

Similar funds

Jeff Yass's Q2 2024 Portfolio in Review

As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass withdrew a net $65.7B in Q2 2024, closing 1,726 positions and reducing 5,607 holdings. Its most notable exit was iShares MSCI USA Quality Factor ETF, an estimated $26.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in NextEra Energy 7.299% Corporate Units worth $127M.

  • Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
  • Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
  • Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
  • Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
  • Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
  • Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
  • Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.